WebSep 17, 2024 · WALTHAM, Mass.-- ( BUSINESS WIRE )-- Palleon Pharmaceuticals, a company pioneering the field of glycan-mediated immune regulation to treat cancer and inflammatory diseases, today announced the completion of a $100 million Series B financing led by Matrix Capital Management, with participation from Series A investors SR One, … WebJul 4, 2024 · Palleon develops glycol-immunology products for cancer and inflammatory diseases. Henlius will have rights to develop Palleon’s bifunctional HER2-Sialidase, currently in preclinical...
Palleon Pharmaceuticals Inc Email Format palleonpharma.com …
WebSep 17, 2024 · Palleon Pharmaceuticals has raised $100m in a Series B financing round to develop drugs targeting glycan-mediated immune regulation to treat cancer and … WebOct 13, 2024 · WALTHAM, Mass.-- ( BUSINESS WIRE )-- Palleon Pharmaceuticals, a clinical-stage company pioneering glyco-immunology drug development to treat cancer and inflammatory diseases, today announced that the U.S. Patent and Trademark Office has issued Patent No.11,459,398 titled, “Conjugates for Targeted Cell Surface Editing.” dbz film streaming ita
Palleon Pharmaceuticals secures $100m in Series B funding
WebAfter Twist and Ginkgo campaigns, Scorpion Capital aims stinger at Harmony Biosciences. Mar 28, 2024 01:40pm. WebApr 9, 2024 · Palleon Pharmaceuticals is the leading biotechnology company developing drugs that target glycan-mediated immune regulation to treat cancer and inflammatory diseases. The company’s proprietary ... WebHe was Co-Founder and Chairman of Ra Pharmaceuticals (NASDAQ RARX, acquired by UCB), founding CEO of SetPoint Medical, and Co-Founder and Chairman of Promedior … ged with honors